Next generation therapeutics for Alzheimer's disease
- PMID: 23703924
- PMCID: PMC3779441
- DOI: 10.1002/emmm.201202307
Next generation therapeutics for Alzheimer's disease
Abstract
To date, no truly effective therapy has been developed for Alzheimer's disease or mild cognitive impairment. In searching for new approaches that may succeed where previous ones have failed, it may be instructive to consider the successful therapeutic developments for other chronic illnesses such as cancer and human immunodeficiency virus.
Copyright © 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.
References
-
- Annweiler C, Llewellyn DJ, Beauchet O. Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. J Alzheimer's Dis. 2013;33:659–674. - PubMed
-
- Bertrand E, Brouillet E, Caillé I, Bouillot C, Cole GM, Prochiantz A, Allinquant B. A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo. Mol Cell Neurosci. 2001;18:503–511. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
